Novel Antifungal Treatment Approved for Vaginal Candidiasis
On June 2,2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls who have begun menstruating.
What I Learned From 40 Years in Pharmacy
Money isn’t everything in this profession.
The Evolution of Pharmacogenomics
Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Naloxone: A Primer for Pharmacists
Become an expert in naloxone to help educate patients.
Lessons Learned from the COVID-19 Vaccine Rollout
Pharmacists reflect on their takeaways from the experience and how to move forward.
Childhood Vaccines During COVID-19 and Beyond
Administering pediatric immunizations can be a window of opportunity for pharmacists to demonstrate their value.
Irritable Bowel Syndrome: A Look at the Treatment Landscape
Pharmacists must keep up to date with the latest in irritable bowel syndrome management.
